INS and diabetes mellitus: The percentages of relapse-free mice in all groups are shown in Figure 1F. Thus, the combination of a low dose of lesogaberan and proinsulin/alum treatments greatly prolonged the diabetes remission periods in newly diabetic NOD mice.